7-Bromobenzothiazole

Catalogued under CAS 767-70-4, 7-bromobenzothiazole (C₇H₄BrNS, molecular weight 214.08 g·mol⁻¹) is a heteroaryl bromide characterized by the fusion of a benzene ring to a thiazole core with the bromine substituent occupying the 7-position, adjacent to the sulfur atom. The compound typically reaches the market as an off-white to pale yellow crystalline powder exhibiting a melting endotherm between 63 °C and 67 °C when assayed by differential scanning calorimetry at a heating rate of 10 K·min⁻¹ under nitrogen flow of 50 mL·min⁻¹. Commercially supplied lots are qualified by assay (GC area% or HPLC at 254 nm) with thresholds commonly set at ≥98.0%, while single-impurity limits for the debrominated analogue or the 6-isomer are held below 0.5% area. The distinction between this positional isomer and its 5- and 6-bromo counterparts rests principally on the electronic and steric environment at the C–Br bond: the adjacent ring sulfur donates electron density mesomerically, reducing the bond’s susceptibility to oxidative addition in palladium-catalysed transformations, yet simultaneously the compact peri-like interaction with the thiazole lone pair can accelerate transmetallation when a coordinating directing group is present. These divergent properties place 7-bromobenzothiazole in a separate performance envelope for medicinal chemistry libraries, phosphorescent materials, and agrochemical lead expansion.

What Distinguishes 7-Bromobenzothiazole from the 5- and 6-Bromo Isomers in Pd-Catalysed Cross-Coupling?

The electronic bias imparted by the endocyclic sulfur atom redistributes the LUMO density across the C₇–Br σ* orbital. In gas-phase density functional theory computations at the B3LYP/6-31+G(d) level reported in comparative reactivity studies, the C–Br bond dissociation energy for the 7-isomer is elevated by approximately 12–18 kJ·mol⁻¹ relative to the 6-isomer, consistent with a slower oxidative addition step when using Pd(PPh₃)₄. However, in the presence of sterically demanding phosphine ligands such as SPhos (2-dicyclohexylphosphino-2′,6′-dimethoxybiphenyl) or XPhos, the rate gap narrows because the catalytic system compensates for the higher activation barrier through accelerated phosphine dissociation. The practical consequence observed in large-batch manufacturing is that achieving >90% conversion in Suzuki–Miyaura couplings with the 7-bromo substrate often mandates a temperature ramp to 85–95 °C in toluene/ethanol/water biphasic mixtures, whereas the 6-bromo isomer can reach full conversion at 65 °C in tetrahydrofuran alone. Simultaneously, the proximity of the bromine to the sulfur atom permits a favourable chelation-assisted transmetallation pathway when using ortho-substituted arylboronic acids carrying pendant oxygen or nitrogen donors; this phenomenon is absent in the 5-bromo isomer, whose reaction coordinate lacks any stabilising non-covalent interaction. Patent literature for benzothiazole-based kinase inhibitors explicitly invokes this regiochemical effect, noting that the 7-bromo intermediate delivers a 15–20% higher yield of the C–C coupled product after recrystallisation compared to the 6-bromo isomer under otherwise identical catalyst loadings of 0.5 mol% Pd₂(dba)₃ and 1.2 mol% SPhos.

The mass-transfer limitations of large-scale couplings (vessel diameter >800 mm, retreat-blade impeller at tip speed 2.5 m·s⁻¹) are compounded with 7-bromobenzothiazole because the substrate partitions strongly into the organic layer of the biphasic system; its log P_ow measured by shake-flask method at pH 7.4 is 2.93. If the aqueous carbonate base concentration falls below 1.8 M, the organic-phase residence time of the heteroaryl bromide becomes the rate-determining factor, leading to stalled reactions and elevated palladium black formation. Pilot-plant process descriptions therefore specify controlled co-dispersion of the toluene stock solution with the aqueous phase through a static mixer (Kenics-type, 12 elements) upstream of the reactor jacket, maintaining a linear velocity of at least 0.8 m·s⁻¹ through the mixer. Published data for this specific configuration indicate that the 7-bromo isomer tolerates a wider range of water-to-organic ratios (0.6:1 to 1.4:1) without phase separation inversion than the 6-bromo analogue, which clumps at ratios below 0.8:1.

Purity Specifications and Residual Solvent Profiles

The research grade is typically packaged under argon in amber glass bottles with a PTFE-lined cap and desiccant pouch to maintain moisture content below the 0.1% threshold. Pilot-grade material, destined for kilo-lab production of preclinical candidates, undergoes additional purification by sublimation at 85–90 °C under 0.05 mbar to suppress the 6-isomer content below 0.2%, a limit derived from the observation that even 0.5% of the isomeric impurity can alter the crystallinity of the final active pharmaceutical ingredient (API) during salt formation with hydrochloric acid, as evidenced by XRPD pattern broadening in the 6–12° 2θ region. Industrial bulk lots, transported in 25-kg fibre drums with antistatic polyethylene liners, are stabilised with 0.02 wt% butylated hydroxytoluene (BHT) to inhibit radical-mediated debromination during prolonged storage at ambient temperatures above 30 °C in tropical warehouses; accelerated ageing tests at 40 °C/75% RH over 12 weeks confirm that unstabilised material accumulates 0.8–1.2% benzothiazole, whereas BHT-stabilised lots remain at <0.4% decomposition.

Managing Light-Induced Discolouration During Bulk Storage

7-Bromobenzothiazole exhibits a photochromic response when exposed to UV-A radiation (315–400 nm), transitioning from near-white to a beige-brown hue within 48 hours under laboratory fluorescent lighting of 800 lux. This effect, attributed to homolytic cleavage of the C–Br bond followed by recombination and polybrominated by-product formation, does not reduce the bulk titrated assay beyond 0.2%, yet the colour change can cause automatic vision-system rejections on pharmaceutical tableting lines where acceptable whiteness indices (CIE L* >92) are part of the inbound material specification. Warehouses handling multi-ton lots therefore specify amber-tinted low-density polyethylene inner bags supplemented with UV-absorber masterbatch or maintain storage areas with UV-filtered lighting. A technical note issued by a major European fine-chemical manufacturer documents that storing 7-bromobenzothiazole in standard transparent double-layered polyethylene bags under UVA intensity of 1.2 mW·cm⁻² led to a ΔE* colour difference of 12.5 after 10 days, while the identical material in an aluminised barrier bag showed ΔE* <1.0 over the same period. The phenomenon is markedly less pronounced in the 5-bromo isomer under equivalent conditions, a difference that has been correlated with the higher spin density at the C₇ position in the triplet excited state.

In applications where colour is irrelevant — such as the synthesis of metal-organic frameworks or as a precursor for mercaptobenzothiazole accelerators in rubber vulcanisation — the photochromic behaviour poses no processing hazard, provided the dispersed solid is conveyed under nitrogen blanketing. Confusion arising from visual inspection alone has, however, caused batch rejection in at least one documented instance at a cGMP intermediate facility, where the receiving quality-control unit flagged a palette as out-of-specification based solely on appearance; subsequent HPLC analysis confirmed an assay of 99.1% with ≤0.15% 6-isomer, highlighting the need for spectrophotometric colour specifications (APHA ≤150 in a 5% w/v acetonitrile solution) rather than subjective visual passes.

Application in Phosphorescent Organic Light-Emitting Diodes (PHOLEDs)

The benzothiazole ring system substituted at C₇ introduces a directional dipole that favours electron-transport character when the bromide is replaced by arylamine donors via Buchwald–Hartwig amination. Several patent filings from display-material consortia describe the conversion of 7-bromobenzothiazole into 7-(diphenylamino)benzothiazole derivatives used as host materials for green-phosphorescent iridium emitters. In a representative sequence, amination with diphenylamine in the presence of Pd₂(dba)₃ (1 mol%), BINAP (2 mol%), and sodium tert-butoxide in toluene at 110 °C proceeds to 93% conversion after 18 hours, producing a glassy solid with a T_g of 68 °C as measured by modulated DSC. The electron-only device mobility measured by space-charge-limited current (SCLC) on an ITO/LiF/Al cathode configuration yielded a value of 1.7 × 10⁻⁴ cm²·V⁻¹·s⁻¹ at an electric field of 0.5 MV·cm⁻¹. This mobility is approximately 1.8 times higher than that of the analogous 6-isomer derivative, a difference attributed to the para-like conjugation path from the donor to the electron-withdrawing thiazole nitrogen being preserved in the 7-substituted system while it is cross-conjugated in the 6-substituted case. The resultant PHOLED devices, incorporating 8 wt% Ir(ppy)₃ dopant, exhibited an external quantum efficiency of 19.4% at 1000 cd·m⁻² with a roll-off to 17.1% at 10,000 cd·m⁻², as characterised by a calibrated integrating sphere and spectroradiometer in accordance with international display metrology standards.

The vacuum-deposition step during device fabrication places an upper tolerable limit on residual non-volatile content. Particulate matter derived from trace palladium residues in the aminated product — even at levels of 50–100 ppm — can generate dark-spot defects exceeding 3 µm diameter, which become visible after 200 hours of accelerated lifetime testing at 85 °C/85% RH. Consequently, synthesis protocols destined for electronic-grade intermediates incorporate a chelating resin treatment (thiourea-functionalised polystyrene beads, 2 g per gram of crude product) followed by gradient sublimation at 170–190 °C and 10⁻⁶ mbar to reduce Pd below the inductively coupled plasma mass spectrometry detection limit of 0.1 ppm. No analogous electronic-grade specification exists for the 5-bromo isomer, as its amination kinetics are sluggish and the resulting hole mobility is insufficient for practical device stacks.

Vulcanisation Accelerator Precursor: Differences from 2-Mercaptobenzothiazole Chemistry

When 7-bromobenzothiazole is subjected to a thiolation step using sodium hydrosulfide in N-methylpyrrolidone at 140 °C, it yields 7-mercaptobenzothiazole, a structural isomer of the commodity accelerator 2-mercaptobenzothiazole (MBT). The position of the thiol group on the benzene ring rather than the thiazole ring drastically alters the zinc-complexation behaviour essential for sulphenamide accelerator formation. In systematic studies using zinc oxide dispersion in squalene as a model rubber system, the 7-mercapto derivative formed a bidentate zinc-thiolate complex with a stability constant log K of 8.2, whereas MBT gives log K 10.4 under the same conditions. The weaker complexation delays the onset of cure, shifting the t_s2 scorch time from 2.4 min to 7.1 min in a natural rubber compound containing 50 phr carbon black N330 and 3 phr sulphur at 150 °C (moving-die rheometer, ARC 2000). This extended scorch safety is valued in thick-section tyre apex compounds where premature crosslinking during injection moulding at nozzle pressures up to 1500 bar would otherwise cause scrap rates above 12%. Published data for this specific configuration is limited to pilot-scale internal mixer trials (Banbury BR1600, 1.6 L net chamber volume, fill factor 0.75, rotor speed 60 rpm), where the replacement of 50% of the MBT charge with 7-mercaptobenzothiazole maintained a tensile strength of 24.3 MPa (ISO 37:2017, type 2 dumbbell) while reducing the Mooney viscosity of the compound ML(1+4) at 100 °C by 7 units, facilitating downstream extrusion.

The reduced tan δ at 60 °C — a predictor of rolling resistance in pneumatic tyres — is consistent with a lower density of sulphur crosslinks of di- and polysulfidic rank, as confirmed by thiol-amine chemical probe analysis. The 7-isomer therefore offers an entry point to delayed-action cure systems that cannot be replicated by the 5- or 6-bromo precursors, which, upon thiolation, produce sterically encumbered mercaptans that fail to complex with zinc oxide in the same stoichiometry.

What Happens When the Substrate is Exposed to Amine-Based Nucleophiles Without Palladium?

A direct nucleophilic aromatic substitution of the bromine atom in 7-bromobenzothiazole by primary or secondary aliphatic amines can be thermally driven at temperatures exceeding 120 °C in polar aprotic solvents. However, this metal-free pathway presents a processing conflict: the benzothiazole ring itself is susceptible to ring-opening by amine attack at the C₂ position when the reaction medium contains water or when the amine possesses a low steric bulk (e.g., methylamine). In a head-to-head comparison with the 6-bromo isomer, the ring-opening by-product reaches 6.4 area% after 24 hours at 130 °C in DMF with 2 equivalents of n-butylamine for 7-bromobenzothiazole, whereas the 6-isomer generates only 1.2% of the corresponding ring-opened thiolate under identical conditions. The increased susceptibility has been rationalised by the anchimeric assistance of the sulfur atom, which stabilises a thiolate-iminium intermediate following amination at C₂. Therefore, any process that foregoes palladium catalysis must maintain strictly anhydrous solvent (<50 ppm water by KF) and use a sterically hindered amine base such as diisopropylethylamine, which exhibits a rate of ring opening 18× slower than n-butylamine. For kilo-scale operations, this constraint drives the adoption of Buchwald–Hartwig conditions despite the added catalyst removal burden, simply because the selectivity window for the metal-free route (processing window ≤±5 °C at 125 °C) is too narrow for robust manufacturing.